Deciphera Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 72 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-10-02: Reporting owner Rosen Oliver; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-10-02: Reporting owner Rosen Oliver; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-10-02: Reporting owner Rosen Oliver; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-10-02: Reporting owner Rosen Oliver; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,746 0 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +207,614 207,614 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,166 0 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +46,137 46,137 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,500 0 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +48,025 48,025 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,121 0 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Rosen Oliver Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +45,883 45,883 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −110,727 0 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +625,607 625,607 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,607 0 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +139,029 139,029 owned after | $1.89 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 0 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +39,550 39,550 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,835 0 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Flynn Daniel Lee Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +151,617 151,617 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Morl Christopher John Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −42,575 0 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Morl Christopher John Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +240,548 240,548 owned after | $3.95 exercise price | 2018-09-20 | |
| 2017-10-02 | Morl Christopher John Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,590 0 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Morl Christopher John Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +20,283 20,283 owned after | $6.13 exercise price | 2018-09-20 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,497 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +138,408 138,408 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,444 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +30,758 30,758 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 0 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +50,850 50,580 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,946 0 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Bristol James Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +67,494 67,494 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,776 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +123,034 123,034 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −97,988 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +553,632 553,632 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,500 0 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +217,525 217,525 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −43,829 0 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Taylor Michael Douglas Director, Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +247,633 247,633 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,236 0 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +35,233 35,233 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,271 0 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Allen Patricia L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +7,181 7,181 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,236 0 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +35,233 35,233 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,271 0 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Benz Edward J. JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +7,181 7,181 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,621 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +173,008 173,008 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,805 0 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +38,448 38,448 owned after | $1.89 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 0 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +5,650 5,650 owned after | $3.95 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,269 0 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-10-02 | Kelly Thomas Patrick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +103,219 103,219 owned after | $6.13 exercise price | 2017-10-02 | |
| 2017-09-28 holding as of filing | Bristol James Arthur Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Bristol James Arthur Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Bristol James Arthur Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.95 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Bristol James Arthur Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.13 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Martin John Richard Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.00 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Taylor Michael Douglas Director, Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Taylor Michael Douglas Director, Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Taylor Michael Douglas Director, Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.95 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Taylor Michael Douglas Director, Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.13 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ross Michael Jay Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.00 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Ratcliffe Liam Director, 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $17.00 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Walsh Dennis Leo Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.00 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Benz Edward J. JR Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.95 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Benz Edward J. JR Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.13 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Allen Patricia L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.95 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Allen Patricia L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.13 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Kelly Thomas Patrick Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Kelly Thomas Patrick Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.89 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Kelly Thomas Patrick Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.95 exercise price | 2017-09-28 | ||
| 2017-09-28 holding as of filing | Kelly Thomas Patrick Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.13 exercise price | 2017-09-28 |